Jason Adams
Vice President & Head of Biopharma Business Development Foundation Medicine
Seminars
Tuesday 31st March 2026
Panel Discussion: Defining a Unified Path Towards IVDR Compliance for Streamlined Approvals
5:20 pm
- How has IVDR changed expectations for evidence generation, documentation, and timelines across regulators, notified bodies, pharma, and diagnostic developers?
- Is there any strategy change in aligning with notified bodies and regulators?
- What are the most common bottlenecks companies encounter during co-development; from clinical trials to MAA and conformity assessment?
